, Tracking Stock Market Picks
Enter Symbol:
Intermune, Inc. (ITMN) [hlAlert]

up 530.54 %

Intermune, Inc. (ITMN) rated Buy by ThinkEquity

Posted on: Wednesday,  Mar 10, 2010  8:25 AM ET by ThinkEquity

ThinkEquity rated Buy Intermune, Inc. (NASDAQ: ITMN) on 03/10/2010. Previously ThinkEquity rated Accumulate Intermune, Inc. (NASDAQ: ITMN) on 01/27/2009., when
the stock price was $11.72. Since then, Intermune, Inc. has gained 530.55% as of 09/26/2014's recent price of $73.90.
If you would have followed the previous ThinkEquity's recommendation on ITMN, you would have gained 530.54% of your investment in 2068 days.

InterMune Pharmaceuticals Inc. develops and commercializes innovative products for the treatment of serious pulmonary and infectious diseases and congenital disorders. The company markets ACTIMMUNE for chronic granulomatous disease and osteopetrosis. The company has active development programs underway for the other disease areas, several of which are in mid-or advanced-stage human testing, known as clinical trials.

Research is at the core of everything we do at ThinkEquity, and we're passionate about it. Employing a disciplined and rigorous process, we scrutinize the spectrum of forces at play in the growth sectors we cover. Starting with a top down analysis, we look closely at the megatrends and industry drivers that create opportunities for innovative companies. We then allocate our resources based on a long-range research roadmap that leads to deep domain expertise and a close working knowledge of the technologies, products, services and people that populate the growth sector landscape. In short, the sum result of the ThinkEquity research process is to identify and affiliate ourselves with the fastest growing private and public companies within our domain verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/10/2010 8:25 AM Buy
as of 12/31/2010
1 Week down  -5.29 %
1 Month up  179.37 %
3 Months up  157.63 %
1 YTD up  169.09 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/21/2009 8:25 AM Buy
16.03 16.00
1/27/2009 8:25 AM Buy
11.72 25.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy